Results 41 to 50 of about 8,472 (213)
Hepatic sinus obstruction syndrome (HSOS) is easy to be misdiagnosed or missed, and there is no unified and effective treatment for it. A patient was considered to have Budd-Chiari syndrome.
Yidan Gao +5 more
doaj +1 more source
In patients with acute‐on‐chronic liver failure (ACLF), esophagogastric variceal bleeding (EGVB) represents a critical complication associated with high short‐term mortality. This study evaluated the efficacy of endoscopic treatment in this specific population and identified prognostic factors associated with 6‐week rebleeding and mortality.
Yanan Sun +7 more
wiley +1 more source
The transjugular intrahepatic portosystemic shunt (TIPS) procedure is performed to create an intrahepatic tract between the hepatic and portal veins which helps to shunt blood away from the hepatic sinusoids.
Kavya Mirchia, MD +8 more
doaj +1 more source
A Case of Ileal Conduit Bleeding Caused by Porto‐Sinusoidal Vascular Disorder
ABSTRACT A 60‐year‐old man presented with recurrent stomal bleeding for 3 years. He had undergone cystoprostatectomy with ileal conduit diversion for bladder cancer 7 years prior. Endoscopy revealed multiple protruding lesions (0.6–0.8 cm) inside the stoma, which were initially suspected to be ectopic varices given concomitant esophageal varices and ...
Lu Yu, Hao Wu, Huan Tong
wiley +1 more source
Is de novo hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt increased?
Background Portal hypertension is a major complication of liver cirrhosis. Transjugular intrahepatic portosystemic shunt is effective in treatment of portal hypertension.
A Hüsing-Kabar +8 more
core +1 more source
Transjugular Intrahepatic Portosystemic Shunt: An Update
It is more than 50 years since the concept of transjugular intrahepatic portosystemic shunt (TIPS) was first introduced as a percutaneous procedure for patients with refractory variceal bleeding and ascites. TIPS has become widely accepted in the management of complications of portal hypertension because it is less invasive than surgery.
Yamamoto, Masayoshi +4 more
openaire +2 more sources
This preclinical study evaluated a novel controlled‐expansion expanded polytetrafluoroethylene (ePTFE)‐covered transjugular intrahepatic portosystemic shunt (TIPS) stent in 11 swine, demonstrating 100% technical success, excellent deployability, and durable 6‐month angiographic patency without thrombosis, migration, fracture, or device‐related toxicity.
Yi Xiang +15 more
wiley +1 more source
Transsplenic access has emerged as a valuable technique for portal venous interventions when conventional transjugular or transhepatic approaches are challenging due to prohibitive anatomy.
Trinity Puno, BS +5 more
doaj +1 more source
Shunt porto-sistémico intra-hepático transjugular.
The case of a 66-year-old woman with several episodes of hemorrhage by esophageal varices and ascites due to portal hypertension is presented. Despite 4 sessions of endoscopic sclerotherapy bleeding recurred.
J M Pisco +7 more
doaj +1 more source
We report a case of life‐threatening airway obstruction due to retropharyngeal‐cervicomediastinal hematomas following transjugular intrahepatic portosystemic shunt or acute variceal bleeding in cirrhosis.
Long Li, Yong Chen
doaj +1 more source

